CN110499345A - 一种维生素k2(MK-7型)的发酵方法 - Google Patents
一种维生素k2(MK-7型)的发酵方法 Download PDFInfo
- Publication number
- CN110499345A CN110499345A CN201910822357.0A CN201910822357A CN110499345A CN 110499345 A CN110499345 A CN 110499345A CN 201910822357 A CN201910822357 A CN 201910822357A CN 110499345 A CN110499345 A CN 110499345A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- control
- stage
- vitamin
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 148
- 230000004151 fermentation Effects 0.000 title claims abstract description 148
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 239000011700 menaquinone-7 Substances 0.000 title claims abstract description 28
- 229940010250 vitamin k 2 Drugs 0.000 title claims abstract description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 62
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000000908 ammonium hydroxide Substances 0.000 claims abstract description 41
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 41
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 41
- 239000001301 oxygen Substances 0.000 claims abstract description 41
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 36
- 239000008103 glucose Substances 0.000 claims abstract description 36
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 235000013557 nattō Nutrition 0.000 claims abstract description 8
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- 238000013329 compounding Methods 0.000 claims abstract description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 60
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 48
- 239000002609 medium Substances 0.000 claims description 34
- 230000003519 ventilatory effect Effects 0.000 claims description 30
- 239000011780 sodium chloride Substances 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 229910052564 epsomite Inorganic materials 0.000 claims description 21
- 235000011187 glycerol Nutrition 0.000 claims description 21
- 239000007836 KH2PO4 Substances 0.000 claims description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 18
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 14
- 229940038504 oxygen 100 % Drugs 0.000 claims description 11
- 239000001888 Peptone Substances 0.000 claims description 10
- 108010080698 Peptones Proteins 0.000 claims description 10
- 235000019319 peptone Nutrition 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000011218 seed culture Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 238000010899 nucleation Methods 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 claims 1
- 235000019143 vitamin K2 Nutrition 0.000 claims 1
- 239000011728 vitamin K2 Substances 0.000 claims 1
- 241001052560 Thallis Species 0.000 abstract description 4
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 210000001082 somatic cell Anatomy 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 239000011772 phylloquinone Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 229940101516 mephyton Drugs 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- -1 platinum vitamin Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/66—Preparation of oxygen-containing organic compounds containing the quinoid structure
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
项目 | 批次 | 发酵单位g/l | 体积L | 产量g |
实验1 | 4 | 80.8 | 36.1 | 2.92 |
实验5 | 4 | 68.6 | 36.2 | 2.48 |
实验6 | 4 | 75.4 | 36.0 | 2.71 |
实验7 | 4 | 76.9 | 36.0 | 2.77 |
实验8 | 4 | 75.4 | 35.9 | 2.70 |
X | 批次 | 发酵单位g/l | 体积L | 产量g |
0.2 | 4 | 72.4 | 36.1 | 2.61 |
0.3 | 4 | 79.9 | 36.2 | 2.89 |
0.4 | 4 | 80.4 | 36.0 | 2.89 |
0.5 | 4 | 81.5 | 36.0 | 2.93 |
0.6 | 4 | 80.7 | 35.9 | 2.89 |
0.7 | 4 | 80.3 | 36.0 | 2.89 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910822357.0A CN110499345B (zh) | 2019-09-02 | 2019-09-02 | 一种维生素k2(MK-7型)的发酵方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910822357.0A CN110499345B (zh) | 2019-09-02 | 2019-09-02 | 一种维生素k2(MK-7型)的发酵方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110499345A true CN110499345A (zh) | 2019-11-26 |
CN110499345B CN110499345B (zh) | 2021-05-28 |
Family
ID=68590944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910822357.0A Active CN110499345B (zh) | 2019-09-02 | 2019-09-02 | 一种维生素k2(MK-7型)的发酵方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110499345B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549079A (zh) * | 2020-06-18 | 2020-08-18 | 内蒙古金达威药业有限公司 | 一种采用微生物发酵法制备维生素k2的方法 |
CN112971148A (zh) * | 2021-04-20 | 2021-06-18 | 郑州路路通医药科技有限公司 | 一种钙维生素d维生素k片剂及其制备方法 |
CN113755402A (zh) * | 2021-10-12 | 2021-12-07 | 淮阴工学院 | 一种纳豆芽胞杆菌高密度发酵培养基及其高密度发酵方法 |
CN114790468A (zh) * | 2022-04-08 | 2022-07-26 | 浙江珲达生物科技有限公司 | 一种mk-7的发酵生产方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1803820A1 (en) * | 2005-12-29 | 2007-07-04 | Gnosis S.p.A. | A process for the preparation of vitamin K2 |
US20070254347A1 (en) * | 2004-12-28 | 2007-11-01 | Japan Bio Science Laboratory Co, Ltd. | Method for producing vitamin K2 from culture of Bacillus natto |
CN103571897A (zh) * | 2013-10-29 | 2014-02-12 | 中国科学院合肥物质科学研究院 | 一种维生素k2及其制备方法 |
CN104328064A (zh) * | 2014-09-16 | 2015-02-04 | 丽水双健生物工程有限公司 | 一种纳豆芽孢杆菌及其在发酵生产维生素k2中的应用 |
CN108410775A (zh) * | 2018-04-27 | 2018-08-17 | 江南大学 | 一株高产维生素k2(mk-7)的纳豆芽孢杆菌及其应用 |
CN109971788A (zh) * | 2019-03-11 | 2019-07-05 | 中国科学院合肥物质科学研究院 | 一种重组纳豆芽孢杆菌的构建方法及其发酵制备维生素k2的方法 |
CN110157654A (zh) * | 2019-05-21 | 2019-08-23 | 江南大学 | 一种纳豆芽孢杆菌重组菌及其构建方法与应用 |
-
2019
- 2019-09-02 CN CN201910822357.0A patent/CN110499345B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070254347A1 (en) * | 2004-12-28 | 2007-11-01 | Japan Bio Science Laboratory Co, Ltd. | Method for producing vitamin K2 from culture of Bacillus natto |
EP1803820A1 (en) * | 2005-12-29 | 2007-07-04 | Gnosis S.p.A. | A process for the preparation of vitamin K2 |
CN103571897A (zh) * | 2013-10-29 | 2014-02-12 | 中国科学院合肥物质科学研究院 | 一种维生素k2及其制备方法 |
CN104328064A (zh) * | 2014-09-16 | 2015-02-04 | 丽水双健生物工程有限公司 | 一种纳豆芽孢杆菌及其在发酵生产维生素k2中的应用 |
CN108410775A (zh) * | 2018-04-27 | 2018-08-17 | 江南大学 | 一株高产维生素k2(mk-7)的纳豆芽孢杆菌及其应用 |
CN109971788A (zh) * | 2019-03-11 | 2019-07-05 | 中国科学院合肥物质科学研究院 | 一种重组纳豆芽孢杆菌的构建方法及其发酵制备维生素k2的方法 |
CN110157654A (zh) * | 2019-05-21 | 2019-08-23 | 江南大学 | 一种纳豆芽孢杆菌重组菌及其构建方法与应用 |
Non-Patent Citations (2)
Title |
---|
EHSAN MAHDINIA ET AL: "Utilization of glucose-based medium and optimization of Bacillus subtilis natto growth parameters for vitamin K (menaquinone-7) production in biofilm reactors", 《BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY》 * |
牟杰等: "纳豆芽孢杆菌生产维生素K2的连续发酵工艺优化", 《食品工业科技》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549079A (zh) * | 2020-06-18 | 2020-08-18 | 内蒙古金达威药业有限公司 | 一种采用微生物发酵法制备维生素k2的方法 |
WO2021253546A1 (zh) * | 2020-06-18 | 2021-12-23 | 内蒙古金达威药业有限公司 | 一种采用微生物发酵法制备维生素k2的方法 |
CN111549079B (zh) * | 2020-06-18 | 2024-05-10 | 内蒙古金达威药业有限公司 | 一种采用微生物发酵法制备维生素k2的方法 |
CN112971148A (zh) * | 2021-04-20 | 2021-06-18 | 郑州路路通医药科技有限公司 | 一种钙维生素d维生素k片剂及其制备方法 |
CN113755402A (zh) * | 2021-10-12 | 2021-12-07 | 淮阴工学院 | 一种纳豆芽胞杆菌高密度发酵培养基及其高密度发酵方法 |
CN114790468A (zh) * | 2022-04-08 | 2022-07-26 | 浙江珲达生物科技有限公司 | 一种mk-7的发酵生产方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110499345B (zh) | 2021-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110499345A (zh) | 一种维生素k2(MK-7型)的发酵方法 | |
CN102203237B (zh) | 用于乙醇生产的孢子形成缺陷嗜热微生物 | |
CN102643770B (zh) | 利用合成培养基纯厌氧生长产丁二酸的大肠杆菌及其应用 | |
CN107475344A (zh) | 一种利用枯草芽孢杆菌发酵生产维生素b2的方法 | |
CN104845896B (zh) | 生产威兰胶的菌株及方法 | |
CN104630166A (zh) | 微生物发酵生产低温葡萄糖氧化酶的方法 | |
Yee et al. | The production of functional γ-aminobutyric acid Malaysian soy sauce koji and moromi using the trio of Aspergillus oryzae NSK, Bacillus cereus KBC, and the newly identified Tetragenococcus halophilus KBC in liquid-state fermentation | |
Taniguchi et al. | Clarification of interactions among microorganisms and development of co-culture system for production of useful substances | |
CN103509832B (zh) | 一种以高浓度磷酸二氢钾为缓冲盐的发酵生产γ-氨基丁酸的方法 | |
CN104630167A (zh) | 海洋微生物发酵生产低温葡萄糖氧化酶的方法 | |
US20080305536A1 (en) | Method for Culturing Microorganisms | |
CN110564580A (zh) | 一种微生物共培养发酵生产含有吡咯喹啉醌食醋的方法 | |
CN112831437B (zh) | 枯草芽孢杆菌及高产吲哚乙酸、高芽孢形成率的发酵方法 | |
CN103451244A (zh) | 一种屎肠球菌在制备l-乳酸中的应用 | |
CN101638674B (zh) | 一种利用蔗糖水解物发酵法生产柠檬酸的方法 | |
CN101638675B (zh) | 一种蔗糖发酵法生产柠檬酸的方法 | |
CN108048496B (zh) | 氧化型辅酶q10的发酵生产方法、及由其制备而得的高含量氧化型辅酶q10 | |
CN110951798A (zh) | γ-聚谷氨酸的生物发酵方法及其应用 | |
CN105586293A (zh) | 一种新的乳酸利用梭菌及其用途 | |
CN103305437B (zh) | 一株l-乳酸铵耐受菌及其应用 | |
Abi et al. | Improved laminaribiose phosphorylase production by Euglena gracilis in a bioreactor: a comparative study of different cultivation methods | |
CN105861410B (zh) | 一种提高酪酸菌生长效率的方法 | |
CN100427583C (zh) | 高糖化酶活的菌种、酶制剂及其制备方法和应用 | |
CN105463007B (zh) | 基于离子束介导技术构建重组大肠杆菌生产辅酶i的方法 | |
CN109161570A (zh) | 一种提高发酵产n-乙酰神经氨酸的方法及发酵液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A fermentation method of vitamin K2 (MK-7 type) Effective date of registration: 20220420 Granted publication date: 20210528 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022350000042 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230413 Granted publication date: 20210528 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022350000042 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Fermentation Method for Vitamin k2 (MK-7 Type) Effective date of registration: 20230418 Granted publication date: 20210528 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023350000121 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210528 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023350000121 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A fermentation method for vitamin k2 (MK-7 type) Granted publication date: 20210528 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2024350000040 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |